Patents by Inventor Timothy Farries

Timothy Farries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10888589
    Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stem cells into the desired phenotype, propagating stem cells and/or facilitating cloning.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: January 12, 2021
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Alan P. Wolffe, Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov
  • Publication number: 20170224741
    Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stem cells into the desired phenotype, propagating stem cells and/or facilitating cloning.
    Type: Application
    Filed: April 13, 2017
    Publication date: August 10, 2017
    Inventors: Alan P. Wolffe, Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov
  • Patent number: 9624509
    Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stem cells into the desired phenotype, propagating stem cells and/or facilitating cloning.
    Type: Grant
    Filed: May 5, 2014
    Date of Patent: April 18, 2017
    Assignee: SANGAMO BIOSCIENCES, INC.
    Inventors: Alan P. Wolffe, Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov
  • Patent number: 9603912
    Abstract: An agent that stimulates antiviral immunity may be used, for the treatment of cancer. A product comprising an immunostimulant and a vector comprising a transgene that promotes death of neoplastic cells, may also be used for simultaneous, sequential or separate administration in the treatment of cancer.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: March 28, 2017
    Assignee: Glrotherapy Limited
    Inventors: Timothy Farries, David Eckland
  • Publication number: 20170021039
    Abstract: The prior art largely suggests that immune competence in a cancer patient would destroy an antigenic viral vector before it transfects host cells with a transgene-rendering therapy futile. We surprisingly found the opposite is true: cancer patients with competent immune systems obtain the most therapeutic benefit from antigenic viral vector, apparently because the antigenic viral vector, apart from transfecting cells with a transgene, induces a humoral immune response, which in turn attacks cells bearing cancer antigen. Our new therapy works particularly well in combination with cytotoxic chemotherapeutic drugs.
    Type: Application
    Filed: October 7, 2016
    Publication date: January 26, 2017
    Applicant: Trizell Ltd.
    Inventors: Timothy FARRIES, David ECKLAND
  • Publication number: 20140234970
    Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stem cells into the desired phenotype, propagating stem cells and/or facilitating cloning.
    Type: Application
    Filed: May 5, 2014
    Publication date: August 21, 2014
    Applicant: Sangamo BioSciences, Inc.
    Inventors: Alan P. Wolffe, Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov
  • Patent number: 8735153
    Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stems cells into the desired phenotype, propagating stem cells and/or facilitating cloning.
    Type: Grant
    Filed: September 24, 2002
    Date of Patent: May 27, 2014
    Assignee: Sangamo BioSciences, Inc.
    Inventors: Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov, Elizabeth J. Wolffe
  • Publication number: 20120164172
    Abstract: An agent that stimulates antiviral immunity may be used, for the treatment of cancer. A product comprising an immunostimulant and a vector comprising a transgene that promotes death of neoplastic cells, may also be used for simultaneous, sequential or separate administration in the treatment of cancer.
    Type: Application
    Filed: September 23, 2010
    Publication date: June 28, 2012
    Inventors: Timothy Farries, David Eckland
  • Publication number: 20060251642
    Abstract: Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stems cells into the desired phenotype, propagating stem cells and/or facilitating cloning.
    Type: Application
    Filed: September 24, 2002
    Publication date: November 9, 2006
    Inventors: Alan Wolffe, Michael Moore, Timothy Farries, Trevor Collingwood, Fyodor Urnov